Skip to content

HealthEquity HQY Return on equity

Return on equity at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
11.8%-11.1pp
Webster Financial Corporation logo
Webster Financial CorporationWBS
10.9%+2.2pp
Willis Towers Watson logo
Willis Towers WatsonWTW
20.7%
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
Centene logo
CenteneCNC
-26.1%-38.7pp
Voya Financial logo
Voya FinancialVOYA

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Calculated from HealthEquity’s reported figures.

Based on trailing twelve months.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's return on equity?
HealthEquity (HQY) reported return on equity of 11.1% in Q1 2026.
How has HealthEquity's return on equity changed year-over-year?
HealthEquity's return on equity increased by 91.7% year-over-year, from 5.8% to 11.1%.
What is the long-term trend for HealthEquity's return on equity?
Over 5 years (2021 to 2026), HealthEquity's return on equity has grown at a 69.3% compound annual growth rate (CAGR), from 0.7% to 10.2%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.